ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Capital Increase/Acquisition 22.12.2008 Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Eckert & Ziegler to Purchase Isotope Company Berlin, 22 December 2008 Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700) today signed an agreement for the acquisition of a business in the radioisotope industry with revenues in excess of 20 mm EUR. The purchase price including cash (net working capital) is estimated to around 6 mm EUR (and includes the assumption of liabilities). The Berlin based specialist for radioactive applications is considering an increase in capital in order to finance the transaction Eckert & Ziegler is one of the largest manufacturers for radioactive components for medical, industrial and scientific applications. It employs about 420 staff members world wide and expects revenues of about 70 mm EUR for 2008. The Board of Directors. Your contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str. 10, D-13125 Berlin Tel.: +49 (0) 30 / 94 10 84-138, Fax 112, E-mail: karolin.riehle@ezag.de, www.ezag.de DGAP 22.12.2008 --------------------------------------------------------------------------- Language: English Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG Robert-Rössle-Str. 10 13125 Berlin Deutschland Phone: +49 (0)30 941 084-0 Fax: +49 (0)30 941 084-112 E-mail: karolin.riehle@ezag.de Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Hamburg, Düsseldorf End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Eckert & Ziegler to Purchase Isotope Company
| Source: EQS Group AG